Literature DB >> 2781294

Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.

C T Dourish1, W Rycroft, S D Iversen.   

Abstract

Exogenous cholecystokinin (CCK) decreases food intake and causes satiety in animals and man. However, it has not been established that endogenous CCK causes satiety or whether the response is mediated by peripheral-type (CCK-A) or brain-type (CCK-B) receptors. The development of potent and selective antagonists for CCK-A (MK-329) and CCK-B (L-365,260) receptors now allows these issues to be addressed. The CCK-A antagonist MK-329 and the CCK-B antagonist L-365,260 increased food intake in partially satiated rats and postponed the onset of satiety; however, L-365,260 was 100 times more potent than MK-329 in increasing feeding and preventing satiety. These results suggest that endogenous CCK causes satiety by an agonist action on CCK-B receptors in the brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2781294     DOI: 10.1126/science.2781294

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  22 in total

1.  Zollinger-Ellison syndrome, antisecretory treatment, and body weight.

Authors:  J L Raoul; J F Bretagne; A Ropert; L Siproudhis; D Heresbach; M Gosselin
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

Review 2.  [Regulation of food intake].

Authors:  W Langhans; E Scharrer
Journal:  Z Ernahrungswiss       Date:  1990-06

3.  G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo.

Authors:  A Nagata; M Ito; N Iwata; J Kuno; H Takano; O Minowa; K Chihara; T Matsui; T Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Role of cholecystokinin in anorexia induction following oral exposure to the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol.

Authors:  Wenda Wu; Hui-Ren Zhou; Kaiyu He; Xiao Pan; Yoshiko Sugita-Konishi; Maiko Watanabe; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2014-01-02       Impact factor: 4.849

5.  Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats.

Authors:  Victoria Cano; Laura Ezquerra; M Pilar Ramos; Mariano Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

6.  Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats.

Authors:  A J Goudie; M J Leathley
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

7.  Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist.

Authors:  M Poncelet; M Arnone; M Heaulme; N Gonalons; C Gueudet; V Santucci; O Thurneyssen; P Keane; D Gully; G Le Fur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

8.  Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.

Authors:  E Vasar; J Harro; A Lang; A Pôld; A Soosaar
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats.

Authors:  G Grignaschi; B Mantelli; C Fracasso; M Anelli; S Caccia; R Samanin
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.

Authors:  I S Ebenezer; B A Baldwin
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.